Edition:
United States

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

110.94USD
4:02pm EDT
Change (% chg)

$1.84 (+1.69%)
Prev Close
$109.10
Open
$109.07
Day's High
$111.25
Day's Low
$108.96
Volume
11,487
Avg. Vol
20,496
52-wk High
$124.31
52-wk Low
$92.28

Chart for

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $4,419.99
Shares Outstanding(Mil.): 40.51
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.87 15.95
EPS (TTM): -- -- --
ROI: -- 14.31 15.19
ROE: -- 15.61 13.87

BRIEF-Taro announces joining of CEO

* Taro Pharmaceutical Industries Ltd - ‍ Uday Baldota has joined company as its chief executive officer ("CEO") effective August 28, 2017​

Sep 01 2017

Indian shrs fall for 3rd day; US-N.Korea tensions spook investors

Aug 9 Indian shares fell for a third consecutive session on Wednesday, dragged down by financial and healthcare stocks, as escalating tensions on the Korean peninsula hit regional markets.

Aug 09 2017

BRIEF-Taro reports quarterly net income per ordinary share $1.35

* Qtrly net income per ordinary share $1.35 Source text for Eikon: Further company coverage:

Aug 08 2017

BRIEF-Taro reports qtrly EPS $2.05

* Qtrly earnings per share $2.05 Source text for Eikon: Further company coverage:

May 22 2017

BRIEF-Crescita Therapeutics announces agreement with Taro Pharmaceuticals for Pliaglis

* Crescita Therapeutics announces agreement with Taro Pharmaceuticals for Pliaglis

Apr 25 2017

Earnings vs. Estimates